Results

MaxCyte books loss as expenses offset 21% rise in revenue

Cell-based therapies group MaxCyte booked a full-year loss after a rise in revenue was more than offset by R&D and marketing spending.

Net losses for...

Tue, 20/04/2021 - 09:42

Associated British Foods H1 profit halves on Primark sales slump; resumes dividend

Primark-owner Associated British Foods resumed its dividend payment at a lower rate after reporting that first-profit halved following a slump in Primark sales as the...

Tue, 20/04/2021 - 07:53

Avast lifts guidance on revenue amid ongoing momentum in Q1

Cybersecurity provider Avast lifted its guidance on annual revenue growth following the sale of its family s mobile business and continued demand seen in the...

Tue, 20/04/2021 - 07:35

Empire Metals annual losses widen as revenue slumps, costs rise

Exploration and resource development company Empire Metals reported wider losses as higher costs and a plunge in revenue dented performance.

For the year ended...

Mon, 19/04/2021 - 08:59

Eqtec annual losses widen as higher costs offset climb in revenue

Gasification technology solutions company Eqtec reported wider annual losses as higher costs offset a climb in revenue.

For the year ended 31 December 2020, pre-tax...

Mon, 19/04/2021 - 08:38

TruFin posts annual loss as costs offset 34% rise in revenue

Fintech company TruFin posted a full-year loss after a rise in revenue was offset by staff costs and other operating expenses.

Pre-tax losses for the...

Mon, 19/04/2021 - 07:42

Energean profit slips on lower energy prices; targets maiden divi in 2022

Gas company Energean said it would target its maiden dividend in 2022 after reporting wider annual losses as revenue fell on lower energy prices....

Mon, 19/04/2021 - 07:33

Epwin start to year better than expected; annual profit falls on pandemic impact

Building products maker Epwin said it performance since the start of the year had been better-than-expected following a sharp fall in annual profit as activity...

Thu, 15/04/2021 - 08:02

Oxford Biomedica sees revenue boost following Covid-19 vaccine response

Cell and gene therapy group, Oxford Biomedica, has seen total revenues increase by 37% to £87.7 million in the year ending 31 December 2020....

Thu, 15/04/2021 - 07:44

Royal Dutch Shell puts energy transition plan to shareholder advisory vote

Royal Dutch Shell has prepared this Energy Transition Strategy publication, which is designed to bring the company’s energy products, services, and investments in line with...

Thu, 15/04/2021 - 07:17

Pages